It’s nice to know that we can turn to someone for help when we can’t get any down here.
Winnipeg, Canada (PRWEB) May 15, 2006 –
According to a recent study conducted by licensed Canadian pharmacy, APTECHA Inc, American seniors will need to spend $7900 a year on prescription drug costs under the new Medicare prescription drug plan to match the same level of savings they would otherwise enjoy on a daily basis with every order from its pharmacy in Canada. But rather than discouraging patients from enrolling in a Medicare prescription drug plan, APTECHA Inc is actively encouraging their customers to join the 37 million American seniors that have already signed up for the program to date.
“We’re encouraging all of our patients to enroll in the least expensive Medicare prescription drug plan in their region, while continuing to use APTECHA as their primary pharmacy,” says Mike Palitsky, CFO at APTECHA Inc. “Combining these two choices offers the best solution when it comes time for an American senior to make a decision about Medicare. They will enjoy great savings immediately in Canada and the peace of mind that comes from knowing they will be covered if their drug costs suddenly rise in the future.”
The solution recommended by Palitsky provides the American senior with the greatest savings and prescription drug coverage across all situations. When a patient’s annual drug costs are low, they enjoy an average savings of 47% on all their prescription drug orders at APTECHA Inc, when compared to pharmacies south of the border. If a patient’s annual drug costs suddenly rise in the future because of a newly diagnosed condition such as cancer, diabetes or heart disease, they can then take advantage of the greater savings offered by their Medicare prescription drug plan’s catastrophic drug coverage benefit.
As an added incentive to keep prescription drug orders flowing north of the border into Canada, Palitsky is also encouraging American seniors to register for APTECHA Inc’s Medicare Companion Plan. Here, 5% of a patient’s total purchases with APTECHA, up to a maximum of $75, are put into a personal Medicare Premium Savings Account and can later be directly applied against the cost of their Medicare prescription drug plan’s monthly premiums.
For Joe and Cheryl Jackman, APTECHA Inc’s Medicare Companion Plan is a welcomed relief when it comes to the high cost of medications in the United States. Together, the Jackmans are set to spend more than $800 on the cost of Medicare premiums alone and more than $4200 on their medications in the coming year. With the solution recommended by Palitsky, APTECHA Inc’s Medicare Companion Plan would contribute a combined total of $98.70 towards the cost of their Medicare premiums and their medication bill would come down to $1974 when filled in Canada.
“We’re really hurting with these drug prices down here and we just don’t know how things are going to go with Medicare,” says Cheryl Jackman, an 80-year-old from Onalaska, Texas. When asked how she felt that a Canadian company is subsidizing her Medicare premiums, Jackman replied, “It’s nice to know that we can turn to someone for help when we can’t get any down here.”
APTECHA Inc is licensed by the Manitoba Pharmaceutical Association in Winnipeg, Manitoba, Canada and has been safely dispensing medications to residents of the United States for 4 years. All Canadian medications are approved for sale by Health Canada and are only dispensed by licensed pharmacists.